Targeted NGS for Drug-Resistant Tuberculosis Research and Surveillance - From Policy to Routine Implementation

We are pleased to invite you to the Illumina Stakeholder Meeting held on the side of The Union conference 2026 "Targeted NGS for Drug-Resistant Tuberculosis (DR-TB) Research and Surveillance - From Policy to Routine Implementation".  

This event aims to foster collaboration and accelerate the adoption of targeted NGS (tNGS) in the fight against drug-resistant TB.  

Join a community of national TB programs, public health laboratories, global health agencies, funders, implementing partners, and technical experts committed to advancing tNGS for DR-TB control. Share implementation experience, explore practical solutions to country-level barriers, and identify opportunities for collaboration and ongoing support. 

What to expect: 

• Exchange practical implementation experience, resources, and lessons with early adopters and countries preparing to implement tNGS. 
• Discuss practical barriers and solutions across workflows, staffing, quality systems, data interpretation, procurement, and funding. 
• Build connections across national programs, global health agencies, funders, implementing partners, and technology providers to support sustainable scale-up. 

Please register by clicking the Register Now button and secure your spot.  

This is an invitation-only event, registration is mandatory and will be closed on 29th October 

^{For Research Use Only. Not for use in diagnostic procedures.M-GL-04937}